[This Week's IPO] Bookbuilding and Subscription Schedule for the Second Week of November

In the second week of November, Ucast, SFC, and ADEL will hold bookbuilding sessions for institutional investors. Hana Aerodynamics, J&TG, C&M, and MBD are scheduled to open subscriptions to retail investors.

<Bookbuilding>

◆Ucast= Founded in 2011, Ucast is a wireless communications solutions company that develops its own equipment and systems for 4G and 5G mobile communications and provides services ranging from network construction to operation. In particular, its proprietary solution integrates the core functions of base stations and communications networks, giving the company the capability to build standalone networks tailored to customers' needs.

The offering comprises 800,000 shares, with an indicative price range of KRW 19,000 to KRW 23,000 per share. Bookbuilding for institutional investors will take place from Nov. 9 to 13, followed by the retail subscription on Nov. 18 and 19. Eugene Investment & Securities is the lead underwriter.

◆SFC= SFC makes key materials used in OLED emitting layers. It develops and manufactures both of its main products, blue hosts and dopants, in-house. Drawing on more than 20 years of accumulated R&D expertise, SFC has brought every stage of the process in-house, from molecular design and synthesis to purification, analysis, and mass production.

The company will offer 5 million shares at an indicative price range of KRW 31,600 to KRW 36,100 per share, for an estimated total offering of KRW 158 billion to KRW 180.5 billion. After bookbuilding for institutional investors from Nov. 9 to 13, it will set the final offering price and hold a retail subscription on Nov. 18 and 19. Mirae Asset Securities is the underwriter.

◆ADEL= Founded in 2016 as a spin-off from Asan Medical Center at the University of Ulsan College of Medicine in Seoul, ADEL is developing treatments for Alzheimer's disease and other neurodegenerative disorders. In particular, it is identifying drug candidates based on antibody-therapy technology that selectively targets disease-specific forms of abnormal proteins that cause disease in the field of neurodegenerative brain disorders.

The company plans to offer 2.17 million shares at an indicative price range of KRW 18,000 to KRW 25,000 per share. Bookbuilding for institutional investors will run from Nov. 12 to 18, followed by a retail subscription on Nov. 23 and 24. Samsung Securities and Mirae Asset Securities are the underwriters.

<Retail Subscriptions>

◆Hana Aerodynamics= The indicative price range is KRW 4,700 to KRW 5,700 per share, putting the estimated total offering at KRW 20.7 billion to KRW 25.8 billion. Bookbuilding for institutional investors ran through Nov. 6, and the retail subscription is scheduled for Nov. 10 and 11. IBK Investment & Securities is the lead underwriter.

Founded in 2007, Hana Aerodynamics is an aerospace manufacturer that handles everything from the design and production of jigs and fixtures to precision machining of parts and assembly of airframe structures. It supplies jigs and fixtures, parts, and assembled structures for commercial aircraft, military aircraft, and helicopters to domestic and overseas customers, including Korea Aerospace Industries (KAI) and Bell Helicopter.

◆J&TG= The indicative price range is KRW 26,400 to KRW 31,900 per share. Bookbuilding for institutional investors will continue through Nov. 9. The company will then set the offering price and hold a retail subscription on Nov. 12 and 13. Daishin Securities is the lead underwriter, with NH Investment & Securities as co-underwriter.

J&TG develops and manufactures carbon materials used in energy storage, utilization, and production, from non-lithium secondary-battery energy storage systems (ESS) to hydrogen fuel cells and water electrolysis. The company has established an in-house production system that covers everything from material development and process design to mass production. Helped by increased supplies to global customers, its revenue grew at an average annual rate of 88.8% from 2021 to 2025.

◆C&M= The indicative price range is KRW 10,000 to KRW 13,000 per share, putting the estimated total offering at KRW 29.5 billion to KRW 38.3 billion. Bookbuilding for institutional investors is scheduled through Nov. 9, followed by a retail subscription on Nov. 12 and 13. Korea Investment & Securities is the lead underwriter.

Drawing on 45 years of foundational motor technology and in-house control of key processes, C&M has established itself as a major supplier to key customers of motor components for electric compressors, steer-by-wire (SBW) systems, and electric power steering (EPS). Long-term orders for electric compressors and automotive electronics products, along with expanded supplies to major customers, have lifted its order backlog to KRW 1.4659 trillion, about 6.1 times last year's revenue, enhancing the visibility of its growth.

◆MBD= The indicative price range is KRW 9,600 to KRW 11,700 per share. Bookbuilding for institutional investors ran through Nov. 6. After setting the final offering price and holding a retail subscription on Nov. 12 and 13, the company aims to list on the KOSDAQ market in November. Hana Securities is the lead underwriter.

Founded in 2015, MBD is a biotech platform company targeting both the precision-medicine and drug-development markets with its automation and standardization technology for three-dimensional cell culture. It has applied precision-control and automation technologies used in semiconductor and electronic-component manufacturing to 3D cell-culture processes, turning a process once dependent on researchers' manual work into an equipment-based, standardized procedure.

This content was produced with the assistance of AI translation services.